Home
Conditions
Nasopharyngeal Carcinoma

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

363 public trials 136 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Completed

Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

NCT03314051

Conditions: Carcinoma, EBV Related Carcinoma, Head and Neck Neoplasms, +12 more
Locations: Not specified

View Trial Details

Completed

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

NCT00953420

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

NCT01326559

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Department of Clinical Oncology, Queen Mary Hospital(QMH), Hong Kong Hong Kong, China

Department of Clinical Oncology, Queen Mary Hospital Hong Kong, China

Department of Clinical Oncology, Tuen Mun Hospital (TMH), Hong Kong Hong Kong, China

Department of Oncology, Princess Margaret Hospital Hong Kong, China

View Trial Details

Completed

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

NCT00431210

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

NCT00516087

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma

NCT01370070

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

NCT01540136

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients

NCT02505139

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +16 more
Locations: Not specified

View Trial Details

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

NCT02523430

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Central laboratory in Fuda cancer hospital Guangzhou, Guangdong, China

View Trial Details

Completed

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

NCT02360501

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma trial results

Related conditions